CannBioRx Life Sciences Corp (ATNFW) — Financial Flexibility Index
CannBioRx Life Sciences Corp (ATNFW) has a Financial Flexibility Index of -0.21x as of June 2025. Free cash flow of $-1.13 Million (operating CF $-1.13 Million minus capex $4.00) represents 0% of total liabilities ($5.33 Million). Also explore net asset momentum of CannBioRx Life Sciences Corp to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CannBioRx Life Sciences Corp Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for CannBioRx Life Sciences Corp across 8 annual periods. Check asset resilience ratio of CannBioRx Life Sciences Corp to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for CannBioRx Life Sciences Corp (2017–2024)
Year-by-year free cash flow to debt coverage for CannBioRx Life Sciences Corp. For the full company profile including market capitalisation, see ATNFW market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.42x | $-1.48 Million | $-1.48 Million | $3.51 Million | ▲ +79.2% |
| 2023 | -2.03x | $-10.92 Million | $-10.92 Million | $5.39 Million | ▼ -38.9% |
| 2022 | -1.46x | $-12.13 Million | $-12.13 Million | $8.31 Million | ▼ -782.0% |
| 2021 | -0.17x | $-3.87 Million | $-3.87 Million | $23.39 Million | ▼ -7.9% |
| 2020 | -0.15x | $-3.87 Million | $-3.87 Million | $25.25 Million | ▲ +35.7% |
| 2019 | -0.24x | $-3.17 Million | $-3.32 Million | $13.31 Million | ▼ -43.7% |
| 2018 | -0.17x | $-758.40K | $-789.23K | $4.57 Million | ▼ -41.2% |
| 2017 | -0.12x | $-497.36K | $-497.36K | $4.23 Million | — |